Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Fox Chase Cancer Center Welcomes Dr. Danish Ahmad
PHILADELPHIA (January 4, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Danish Ahmad, MD, as an assistant professor in the Department of Medicine for the Division of Pulmonary, Sleep and Critical Care Medicine.
Ahmad earned his undergraduate degree in physiology and neurobiology at the University of Maryland and attended the University of Maryland School of Medicine. He graduated with his medical degree in 2011 and completed his internal medicine residency at Drexel University College of Medicine.
He stayed on at Drexel for a pulmonary critical care fellowship, where he was named chief pulmonary critical care fellow. He subsequently completed his interventional pulmonology fellowship at the Washington University School of Medicine in St. Louis.
He began his academic career at Penn State College of Medicine in 2018, where he served on numerous committees and in leadership roles. He was an integral member of the thoracic multidisciplinary quality improvement committee and the thoracic oncology disease team. He also served as the director of the lung cancer screening program.
Ahmad’s research interests are in the field of interventional pulmonology. He has been the site principal investigator for multiple bronchoscopy and pleural disease trials. He has authored multiple peer-reviewed publications and several book chapters.
He has also received multiple accolades for his research endeavors. He is a member of numerous professional societies, including the American College of Chest Physicians, the American Thoracic Society, the American Association for Bronchology and Interventional Pulmonology, and the Society for Advanced Bronchoscopy.
Ahmad began his tenure at Fox Chase on November 8.
Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 888-369-2427